Maintenance therapy in duodenal and gastric ulcer disease: survey of practice amongst British gastroenterologists.
We have used a postal questionnaire to obtain data on the practice of maintenance therapy for peptic ulcer disease by members of the British Society of Gastroenterology. Completed questionnaires were returned by 434 members. Ninety-six per cent used maintenance therapy for patients with duodenal ulcer and 81% for gastric ulcer. Maintenance therapy was considered to be safe (duodenal ulcer 91%; gastric ulcer 78%), acceptable to patients (duodenal ulcer gastric ulcer 89%; gastric ulcer 80%) and to reduce the incidence of ulcer complications (duodenal ulcer 81%; gastric ulcer 68%). There was consensus that increasing age of patient, current use of non-steroidal anti-inflammatory drugs, previous ulcer complications, and ulcer relapse after surgery were relatively strong indications for maintenance therapy. However, the proportion of patients who received maintenance therapy varied widely amongst respondents (from < 10% to > 50%). There was no agreement on the optimal duration of therapy, nor on management of patients who relapsed during maintenance therapy. It appears that the criteria for use of maintenance therapy need to be better defined, and that established knowledge about the practice of maintenance therapy should be better disseminated and acted upon.
Boyd
E J
EJ
Ninewells Hospital and Medical School, Dundee, UK.
Penston
J G
JG
Wormsley
K G
KG
D000367:Age Factors; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005762:Gastroenterology / Q000379:methods; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D010818:Practice Patterns, Physicians'; D013276:Stomach Ulcer / Q000188:drug therapy*; D006113:United Kingdom
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D005938:Glucocorticoids